| Bioactivity | (R,R)-CPI-1612 is the inactive isomer of CPI-1612 (HY-136285), and can be used as an experimental control. CPI-1612 is a highly potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor with an IC50 of 8.1 nM for EP300 HAT. CPI-1612 has an anticancer activity[1]. |
| Name | (R,R)-CPI-1612 |
| CAS | 2374972-35-5 |
| Formula | C27H26N6O |
| Molar Mass | 450.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jonathan E Wilson, et al. Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor. ACS Med Chem Lett. 2020 Apr 23;11(6):1324-1329. |
(R,R)-CPI-1612
CAS: 2374972-35-5 F: C27H26N6O W: 450.53
(R,R)-CPI-1612 is the inactive isomer of CPI-1612 (HY-136285), and can be used as an experimental control. CPI-1612 is a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.